e-ISSN: 2249-3387
logo

American Journal of PharmTech Research

Published

Docking Studies of 1 3 4 Thiadiazole Derivatives against target Protein PknG from Mycobacterium Tuberculosis

Published in June 2014 Issue 3 (Vol. 4, Issue 3, 2014)

Docking Studies of 1 3 4 Thiadiazole Derivatives against target Protein PknG from Mycobacterium Tuberculosis - Issue cover

Abstract

1,3,4 – thiadiazole derivatives derived from various reaction sequences with slight modifications in the side chain with primary amine group at 5th position in the thiadiazole ring. The docking studies were done by using scroodinger software version against the enzyme protein kinase. The structures of all the compounds were drawn using chemdraw software version 8.0. All the thiadiazole derivatives showed satisfactory ligand binding energy between -2.70 to -5.60 k.cal /mole. Compounds A3, A21,M34&M36 showed better glide score with -5.4, -4.9, -4.7 and-4.00 respectively.

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Article Information

AJPTR43048

AJPTR-01-001020

2014-06-01

Article Impact

Views:5,299
Downloads:1,672

How to Cite

APA
MLA
Chicago
Harvard
Vancouver
IEEE
ACM
ACS
ABNT
Turabian
RIS (EndNote/Zotero/Mendeley)
BibTeX

D.Sivakumar & G.Geetha (2014). Docking Studies of 1 3 4 Thiadiazole Derivatives against target Protein PknG from Mycobacterium Tuberculosis. American Journal of PharmTech Research, 4(3), xx-xx. https://ajptr.com/articles/AJPTR43048

Article Actions